ASCRS 2024: CoFi integrates with CareCredit and marks participation milestone for ophthalmologists and optometrists

News
Video

Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration

At this year's ASCRS meeting in Boston, Massachusetts, Ophthalmology Times spoke with CoFi CEO Sean Hanlon. Here's what he had to say about CoFi's recent milestones, including the company's partnership with CareCredit.

Editor's note: The below transcript has been lightly edited for clarity.

Hi, I'm Sean Hanlon. I'm the CEO of CoFi. CoFi is a payment software company that enables patients to pay multiple providers involved in a surgery at one time. And we're really excited to be here at ASCRS and ASOA in Boston. We're based in Boston, so we're excited that the show is here, and it's great to see everybody.

A couple things that we're particularly excited about. Number one is we have announced the launch of our new integration with CareCredit. We're enabling multi-party or multi-provider patient financing, so patients can finance an entire procedure, including the surgeons' fees and any of their surgical partners' fees, like a surgery center, or a comanaging optometrist, and so on. The patient can have a single financing event. Those other partners just simply need to have a CoFi account in order to receive their funds. And so both CoFi and CareCredit are excited about this partnership, and excited to launch it; nationally, it's now commercially available.

The other thing we're excited about is CoFi, since we launched our company and launched our product, I should say, just under 3 years ago, we've now eclipsed 5,000 ophthalmologists and optometrists on our platform, a number that's growing by the hundreds every month. I think that's a testament to the fact that we've built, you know, a product that's solving some real needs in the market around payment compliance and payment convenience for patients, and convenience and sort of reduction of administrative burden for practices. So, always excited to come to ASCRS, and particularly excited this year. Hope to see folks while they're here or connect with you after the meeting. Thank you.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.